Patients taking insulin or sulfonylureas with GLP-1 medications should be alert for hypoglycemia symptoms and contact their provider if these occur
Patients should follow the dosing instructions on the product packaging or as advised by their healthcare professional, avoiding exceeding the recommended dose
Routine monitoring: Attend all scheduled follow-up appointments for monitoring of weight, blood pressure, blood glucose, and assessment of treatment efficacy and adverse effects
It may also be more acceptable for someone starting GLP-1 therapy who wants to test tolerance before moving to an injectable plan, though that decision should always be made by a qualified doctor [3]
Ozempic Gallbladder Injuries and Side Effects Research indicates a connection between Ozempic and severe gastrointestinal events, specifically gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis)
Semaglutide delays gastric emptying, slowing the time it takes for food to leave the stomach
